Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 564

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Regulation of the p53 Tumor Suppressor Protein

Open access
Oren, Moshe·1999·Journal of Biological Chemistry

Abstract

c-Jun N-terminal kinase Mutations in the p53 tumor suppressor gene occur in about 50% of all human tumors, making it the most frequent target for genetic alterations in cancer (for recent reviews on p53 see Refs. 1Hansen R. Oren M. Curr. Opin. Genet. Dev. 1997; 7: 46-51Crossref PubMed Scopus (206) Google Scholar, 2Levine A.J. Cell. 1997; 88: 323-331Abstract Full Text Full Text PDF PubMed Scopus (6697) Google Scholar, 3Agarwal M.L. Taylor W.R. Chernov M.V. Chernova O.B. Stark G.R. J. Biol. Chem. 1998; 273: 1-4Abstract Full Text Full Text PDF PubMed Scopus (646) Google Scholar, 4Almog N. Rotter V. Biochim. Biophys. Acta. 1998; 1378: R43-R54PubMed Google Scholar, 5Prives C. Hall P.A. J. Pathol. 1999; 187: 112-126Crossref PubMed Scopus (1225) Google Scholar). Such mutations probably facilitate carcinogenesis primarily through abrogating the tumor suppressor activities of the wild type p53 protein, although at least some forms of tumor-associated mutant p53 proteins may also contribute overt oncogenic activities (gain of function). Excessive wild type p53 activity gives rise to a variety of cellular outcomes, most notably cell cycle arrest and apoptosis. These cellular effects of wild type p53 can reduce cancer incidence through elimination of cancer-prone cells from the replicative pool. However, such effects might become very undesirable if occurring in a normal, unperturbed cell. p53 activity must therefore be kept under tight control, being unleashed only when a cell accumulates lesions that may otherwise drive it into a cancerous state. The signals and mechanisms that regulate p53 activity, maintaining it at low levels under normal conditions and turning it on in cancer-prone cells, are the subject of this review.p53-activating SignalsUnder normal conditions, p53 is most probably latent. Consequently, it does not interfere with cell cycle progression and cell survival. Moreover, p53 knock-out mice appear in most cases to undergo proper development and maturation (6Donehower L.A. Harvey M. Slagle B.L. Mcarthur M.J. Montgomery C.A. Butel J.S. Bradley A. Nature. 1992; 356: 215-221Crossref PubMed Scopus (4009) Google Scholar), suggesting that p53 is not essential for the normal performance of cells within the body. However, a variety of conditions can lead to rapid induction of p53 activity (Fig. 1). The common denominator of these conditions is that they represent various types of stress, which are likely to favor the emergence of cancer-bound cells. Such conditions include direct DNA damage (7Kastan M.B. Onyekwere O. Sidransky D. Vogelstein B. Craig R.W. Cancer Res. 1991; 51: 6304-6311PubMed Google Scholar, 8Maltzman W. Czyzyk L. Cell. Biol. PubMed Scopus Google Scholar, A. PubMed Scopus Google damage to in the proper and of the cellular genetic the C.A. C.A. PubMed Scopus Google L.A. A. Dev. PubMed Scopus Google Scholar), C. A.J. Nature. PubMed Scopus Google Scholar), A. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), and to A. PubMed Scopus Google Scholar). of is a the rapid induction of p53 activity in to damage to that cells such damage are p53 may also to DNA M.L. A.J. Google Scholar, R. D. Rotter V. 1999; PubMed Scopus Google Scholar). The of p53 in maintaining it the of the Nature. 1992; PubMed Scopus Google Scholar). p53 activity is a variety of oncogenic and D. PubMed Scopus Google Scholar, M. D. Cell. 1997; 88: Full Text Full Text PDF PubMed Scopus Google Scholar, M. Dev. 7: PubMed Scopus Google Scholar, A. A. M. J. B. Oren M. J. 1999; PubMed Scopus Google Scholar), a direct oncogenic and the tumor suppressor of p53 of p53 induction of the p53 through alterations in the p53 in the of of the p53 gene a if in such Consequently, the of the p53 gene very recent not that the of is it that p53 levels rise A.J. Nature. PubMed Scopus Google Scholar). rise may be of the of for in the p53 D. Oren M. M. J. Google to the of the p53 gene to the and to be D. B. J. Rotter V. Google Scholar). The induction of and may at However, it does DNA and are at of DNA damage and rise to cancer-prone cells. of p53 levels under such conditions the cells in a of is DNA damage stress, p53 and does not interfere with normal cellular However, if conditions that for a p53 the of levels of p53 that such a be rapid and of p53 of cells to signals can lead within a to a in p53 some this can be of the p53 probably of a through the of this J. PubMed Scopus Google Scholar). also that p53 can p53 through to J. C. W. J. PubMed Scopus Google Scholar, C.A. Cell. Biol. 1997; PubMed Scopus Google Scholar). it is that the of p53 in to through is the in the of p53 is a very protein, turning with a a A. M. C.A. Oren M. Cell. Biol. PubMed Scopus Google Scholar). to DNA damage and types of stress, p53 is (7Kastan M.B. Onyekwere O. Sidransky D. Vogelstein B. Craig R.W. Cancer Res. 1991; 51: 6304-6311PubMed Google Scholar, 8Maltzman W. Czyzyk L. Cell. Biol. PubMed Scopus Google Scholar). rapid in p53 a for is in cells with is mos

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.274.51.36031

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 68

  1. Hansen, 1997, Curr. Opin. Genet. Dev., 7, 46, 10.1016/S0959-437X(97)80108-6 · DOI · Paper page
  2. Levine, 1997, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
  3. Agarwal, 1998, J. Biol. Chem., 273, 1, 10.1074/jbc.273.1.1 · DOI · Paper page
  4. Almog, 1998, Biochim. Biophys. Acta, 1378, R43
  5. Prives, 1999, J. Pathol., 187, 112, 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3 · doi:10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3
  6. Kastan, 1991, Cancer Res., 51, 6304
  7. Maltzman, 1984, Mol. Cell. Biol., 4, 1689
  8. Huang, 1996, Proc. Natl. Acad. Sci. U. S. A., 93, 4827, 10.1073/pnas.93.10.4827 · DOI · Paper page
  9. Cross, 1995, Science, 267, 1353, 10.1126/science.7871434 · DOI · Paper page
  10. Linke, 1996, Genes Dev., 10, 934, 10.1101/gad.10.8.934 · DOI · Paper page
  11. Ohnishi, 1996, J. Biol. Chem., 271, 14510, 10.1074/jbc.271.24.14510 · DOI
  12. Forrester, 1996, Proc. Natl. Acad. Sci. U. S. A., 93, 2442, 10.1073/pnas.93.6.2442 · DOI · Paper page
  13. Smith, 1995, Oncogene, 10, 1053
  14. Offer, 1999, FEBS Lett., 450, 197, 10.1016/S0014-5793(99)00505-0 · DOI
  15. Hermeking, 1994, Science, 265, 2091, 10.1126/science.8091232 · DOI · Paper page
  16. Debbas, 1993, Gene Dev., 7, 546, 10.1101/gad.7.4.546 · DOI · Paper page
  17. Damalas, 1999, EMBO J., 18, 3054, 10.1093/emboj/18.11.3054 · DOI · Paper page
  18. Reich, 1984, Nature, 308, 199, 10.1038/308199a0 · DOI · Paper page
  19. Ginsberg, 1990, Oncogene, 5, 1285
  20. Reisman, 1993, Cell Growth Differ., 4, 57
  21. Fu, 1996, EMBO J., 15, 4392, 10.1002/j.1460-2075.1996.tb00812.x · DOI
  22. Mosner, 1995, EMBO J., 14, 4442, 10.1002/j.1460-2075.1995.tb00123.x · DOI · Paper page
  23. Fontoura, 1997, Mol. Cell. Biol., 17, 3146, 10.1128/MCB.17.6.3146 · DOI
  24. Rogel, 1985, Mol. Cell. Biol., 5, 2851
  25. Hupp, 1992, Cell, 71, 875, 10.1016/0092-8674(92)90562-Q · DOI · Paper page
  26. Bayle, 1995, Proc. Natl. Acad. Sci. U. S. A., 92, 5729, 10.1073/pnas.92.12.5729 · DOI
  27. Wolkowicz, 1995, Proc. Natl. Acad. Sci. U. S. A., 92, 6842, 10.1073/pnas.92.15.6842 · DOI
  28. Hupp, 1995, J. Biol. Chem., 270, 18165, 10.1074/jbc.270.30.18165 · DOI
  29. Gu, 1997, Cell, 90, 595, 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
  30. Waterman, 1998, Nat. Genet., 19, 175, 10.1038/542 · DOI · Paper page
  31. Lambert, 1998, J. Biol. Chem., 273, 33048, 10.1074/jbc.273.49.33048 · DOI · Paper page
  32. Shaulsky, 1990, Oncogene, 5, 1707
  33. Lozano, 1998, Biochim. Biophys. Acta, 1377, M55
  34. Freedman, 1999, Cell. Mol. Life Sci., 55, 96, 10.1007/s000180050273 · DOI · Paper page
  35. Juven-Gershon, 1999, Mol. Med., 5, 71, 10.1007/BF03402141 · DOI
  36. Chen, 1996, Mol. Cell. Biol., 16, 2445, 10.1128/MCB.16.5.2445 · DOI · Paper page
  37. Haupt, 1996, EMBO J., 15, 1596, 10.1002/j.1460-2075.1996.tb00504.x · DOI · Paper page
  38. Thut, 1995, Science, 267, 100, 10.1126/science.7809597 · DOI · Paper page
  39. Lu, 1995, Proc. Natl. Acad. Sci. U. S. A., 92, 5154, 10.1073/pnas.92.11.5154 · DOI · Paper page
  40. Thut, 1997, Gene Dev., 11, 1974, 10.1101/gad.11.15.1974 · DOI · Paper page
  41. Barak, 1993, EMBO J., 12, 461, 10.1002/j.1460-2075.1993.tb05678.x · DOI · Paper page
  42. Wu, 1993, Genes Dev., 7, 1126, 10.1101/gad.7.7a.1126 · DOI · Paper page
  43. Perry, 1993, Proc. Natl. Acad. Sci. U. S. A., 90, 11623, 10.1073/pnas.90.24.11623 · DOI
  44. Wu, 1997, Mol. Med., 3, 441, 10.1007/BF03401691 · DOI · Paper page
  45. Landers, 1994, Oncogene, 9, 2745
  46. Sun, 1998, Science, 282, 2270, 10.1126/science.282.5397.2270 · DOI · Paper page
  47. Maki, 1996, Cancer Res., 56, 2649
  48. Kubbutat, 1997, Mol. Cell. Biol., 17, 460, 10.1128/MCB.17.1.460 · DOI · Paper page
  49. Fuchs, 1998, Genes Dev., 12, 2658, 10.1101/gad.12.17.2658 · DOI · Paper page
  50. Fuchs, 1998, Oncogene, 17, 1483, 10.1038/sj.onc.1202184 · DOI
  51. Meek, 1998, Cell. Signal., 10, 159, 10.1016/S0898-6568(97)00119-8 · DOI
  52. Giaccia, 1998, Genes Dev., 12, 2973, 10.1101/gad.12.19.2973 · DOI · Paper page
  53. Jayaraman, 1999, Cell. Mol. Life Sci., 55, 76, 10.1007/s000180050271 · DOI
  54. Shieh, 1999, EMBO J., 18, 1815, 10.1093/emboj/18.7.1815 · DOI · Paper page
  55. Unger, 1999, EMBO J., 18, 1805, 10.1093/emboj/18.7.1805 · DOI · Paper page
  56. Banin, 1998, Science, 281, 1674, 10.1126/science.281.5383.1674 · DOI · Paper page
  57. Canman, 1998, Science, 281, 1677, 10.1126/science.281.5383.1677 · DOI · Paper page
  58. Khanna, 1995, Oncogene, 11, 609
  59. Blattner, 1999, Oncogene, 18, 1723, 10.1038/sj.onc.1202480 · DOI · Paper page
  60. Mayo, 1997, Cancer Res., 57, 5013
  61. Kubbutat, 1999, Cell Growth Differ., 10, 87
  62. Shaw, 1996, Oncogene, 12, 921
  63. Hupp, 1999, Cell Mol. Life Sci., 55, 88, 10.1007/s000180050272 · DOI
  64. de Stanchina, 1998, Genes Dev., 12, 2434, 10.1101/gad.12.15.2434 · DOI · Paper page
  65. Palmero, 1998, Nature, 395, 125, 10.1038/25870 · DOI · Paper page
  66. Bates, 1998, Nature, 395, 124, 10.1038/25867 · DOI · Paper page
  67. Shaulian, 1997, Oncogene, 15, 2717, 10.1038/sj.onc.1201453 · DOI
  68. Leri, 1999, Am. J. Pathol., 154, 567, 10.1016/S0002-9440(10)65302-3 · DOI

Cited by

See all 564

Metadata

Authors
Oren, M.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1999-12
Volume
274
Issue
51
Pages
36031-36034
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2148958834
Cited by
564
References
23
FWCI
21.62
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation of the p53 Tumor Suppressor Protein. https://app.cochat.ai/papers/10.1074/jbc.274.51.36031
The paper
Oren, M. (1999). Regulation of the p53 Tumor Suppressor Protein. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.274.51.36031

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.